Skip to main content

Table 2 Neurophysiological profiles of symptomatic ATTRA97S-PN at the first and the last evaluations

From: Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort

Family / Patient

Study

NIS

SNCS

MNCS

CTS

QST

CASS

Follow-up Time (years)

L ulnar SNAP amplitude (µV)

L sural SNAP amplitude (µV)

L ulnar

CMAP amplitude

(mV)

L fibular

CMAP amplitude

(mV)

L tibial

CMAP amplitude

(mV)

VDT

LUL/LLL

CDT

LUL/LLL

HPS

LUL/LLL

Patients with sensory and autonomic polyneuropathy at presentation.

  A3a

1st

18

20.9a

11

10a

3.2

14.3

Severe, R

+a/+

+a/+

+a/+

5

4

Last

20

22a

10

10.3a

3.4

10.6

Severe, R

+a/+

+a/+

+a/ +

5

  A4

1st

10

20

11

8.3

3.2

15.7

Mod, B

-/ -

-/+

+/+

3

4

Last

12

22

9.1

10.2

4.2

16.5

Mod, B

-/ -

-/+

+/+

3

  A5

1st

10

27

9.1

10.8

6

12.7

 A

-/+

-/-

+/+

4

3

Last

10

30

10.7

10.9

6.2

10.7

 A

-/+

-/-

+/+

3

  B2

1st

12

16.8

11.3

10.4

3.3

11.1

 A

+/++

-/+

NA

3

3

Last

12

12.7

11.3

10.5

3.9

8.1

 A

+/++

-/+

NA

4

Patients with sensory, motor and autonomic polyneuropathy at presentation.

  A1

1st

84

NR

NR

2.3

NR

0.8

Severe, B

++/++

++/++

NA

NA

6 (death)

Last

145

NR

NR

NR

NR

NR

U

NA

NA

NA

NA

  A2

1st

30

12.6

4.5

8.2

1.4

3.9

Severe, B

++/++

-/+

-/+

5

4

Last

60

4.7

NR

5

0.5

1.3

Severe, B

++/++

+/++

+/++

7

  B1

1st

92

NR

NR

1.5

NR

NR

Severe, B

++/++

++/++

++/++

NA

3 (death)

Last

152

NR

NR

NR

NR

NR

U

++/++

++/++

++/++

NA

  C1

1st

72

8

NR

3.8

NR

4.2

Severe, B

++/++

++/++

+/++

9

5

Last

109

4.4

NR

2.5

NR

2.4

Severe, B

++/++

++/++

++/++

NA

  D1

1st

44

4.4

4

6.5

1.9

6

Severe, R

Mod, L

++/++

++/++

++/++

6

5

Last

66

NR

NR

6

1.2

3.5

Severe, R

Mod, L

++/++

++/++

NA

7

  1. NIS neuropathy impairment score, SNCS sensory nerve conduction study, MNCS motor nerve conduction study, L left, SNAP sensory nerve action potential, µv microvolts, CMAP compound muscle action potential, mV millivolts, CTS carpal tunnel syndrome, QST quantitative sensory test, VDT vibratory detection threshold, CDT cold detection threshold, HPS heat pain sensation, LUL left upper limb, LLL left lower limb, CASS composite autonomic severity score, R right, Mod moderate, B bilateral, A absent, NR no response, U undetermined, +: >95th to 99th percentile, ++: >99th percentile, -: >5th to < 95th percentile, NA non applicable,
  2. a patient A3 had congenital transverse deficiency of the left hand. (Studies were done on the right side.),
  3. Reference values: SNCS: ulnar  10µV, sural  6µV, MNCS: ulnar  6mV, fibular  2mV, tibial  5mV